Integrated DNA Technologies, a leading US oligonucleotide synthesis firm, has purchased the oligo business of VH Bio, based in Gateshead, the UK. IDT will supply VH Bio's customers from its own state-of-the-art facility in Leuven, Belgium, while building on the local customer service for which VH Bio has been renowned in the UK. Financial terms have not been disclosed.
As a result, current VH Bio oligo customers will have access to a much broader range of products, with 100% quality control-checked sequences and next-day delivery. VH Bio will continue to distribute its full range of other products for immunologists/molecular biologists.
IDT and VH Bio have also announced an agreement to work together to grow IDT's oligonucleotide business in the UK. The two companies will combine efforts to introduce the US group's market-leading products to scientists throughout the country.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze